Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 275

1.

Two-Stage Revascularization in Patients with Acute Myocardial Infarction and Massive Coronary Thrombosis.

Vyshlov EV, Krylov AL, Syrkina AG, Alexeeva YV, Demyanov SV, Baev AE, Markov VA, Ryabov VV.

Kardiologiia. 2019 Mar 7;59(2):5-9. doi: 10.18087/cardio.2019.2.10224. Russian.

PMID:
30853015
2.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
3.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators.

Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2.

PMID:
30291013
4.

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.

Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B; COMMANDER HF Investigators.

N Engl J Med. 2018 Oct 4;379(14):1332-1342. doi: 10.1056/NEJMoa1808848. Epub 2018 Aug 27.

5.

Rebuilding C60: Chlorination-Promoted Transformations of the Buckminsterfullerene into Pentagon-Fused C60 Derivatives.

Brotsman VA, Tamm NB, Markov VY, Ioffe IN, Goryunkov AA, Kemnitz E, Troyanov SI.

Inorg Chem. 2018 Jul 16;57(14):8325-8331. doi: 10.1021/acs.inorgchem.8b00976. Epub 2018 Jun 29.

PMID:
29957937
6.
7.

Facile Separation, Spectroscopic Identification, and Electrochemical Properties of Higher Trifluoromethylated Derivatives of [70]Fullerene.

Kosaya MP, Rybalchenko AV, Lukonina NS, Mazaleva ON, Ioffe IN, Markov VY, Troyanov SI, Sidorov LN, Tamm NB, Goryunkov AA.

Chem Asian J. 2018 May 20. doi: 10.1002/asia.201800590. [Epub ahead of print]

PMID:
29781151
8.

Chlorination-promoted skeletal transformation of IPR C76 discovered via trifluoromethylation under the formation of non-IPR C76(CF3)nFm.

Tamm NB, Brotsman VA, Markov VY, Kemnitz E, Troyanov SI.

Dalton Trans. 2018 May 22;47(20):6898-6902. doi: 10.1039/c8dt00984h.

PMID:
29708560
9.

Evaporation Study of an Ionic Liquid with a Double-Charged Cation.

Chilingarov NS, Zhirov MS, Shmykova AM, Martynova EA, Glukhov LM, Chernikova EA, Kustov LM, Markov VY, Ioutsi VA, Sidorov LN.

J Phys Chem A. 2018 May 17;122(19):4622-4627. doi: 10.1021/acs.jpca.8b02488. Epub 2018 May 7.

PMID:
29684267
10.

An experience in the clinical use of specific immunoglobulin from horse blood serum for prophylaxis of Ebola haemorrhagic fever.

Borisevich IV, Chemikova NK, Markov VI, Krasnianskiy VP, Borisevich SV, Rozhdestvenskiy EV.

Vopr Virusol. 2017;62(1):25-9.

PMID:
29323843
11.

Cognitive Function in a Randomized Trial of Evolocumab.

Giugliano RP, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, Schneider J, Wang H, Keech A, Pedersen TR, Sabatine MS, Sever PS, Robinson JG, Honarpour N, Wasserman SM, Ott BR; EBBINGHAUS Investigators.

N Engl J Med. 2017 Aug 17;377(7):633-643. doi: 10.1056/NEJMoa1701131.

12.

Physicochemical Parameters Affecting the Electrospray Ionization Efficiency of Amino Acids after Acylation.

Hermans J, Ongay S, Markov V, Bischoff R.

Anal Chem. 2017 Sep 5;89(17):9159-9166. doi: 10.1021/acs.analchem.7b01899. Epub 2017 Aug 16.

13.

Relationships of growth factors, proinflammatory cytokines, and anti-inflammatory cytokines with long-term clinical results of autologous bone marrow mononuclear cell transplantation in STEMI.

Ryabov VV, Kirgizova MA, Suslova TE, Karas SI, Markov VA, Karpov RS.

PLoS One. 2017 May 30;12(5):e0176900. doi: 10.1371/journal.pone.0176900. eCollection 2017.

14.

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE; ACCELERATE Investigators.

N Engl J Med. 2017 May 18;376(20):1933-1942. doi: 10.1056/NEJMoa1609581.

15.

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators.

N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.

16.

Tightly Bound Double-Caged [60]Fullerene Derivatives with Enhanced Solubility: Structural Features and Application in Solar Cells.

Brotsman VA, Ioutsi VA, Rybalchenko AV, Markov VY, Belov NM, Lukonina NS, Troyanov SI, Ioffe IN, Trukhanov VA, Galimova GK, Mannanov AA, Zubov DN, Kemnitz E, Sidorov LN, Magdesieva TV, Paraschuk DY, Goryunkov AA.

Chem Asian J. 2017 May 18;12(10):1075-1086. doi: 10.1002/asia.201700194. Epub 2017 Apr 25.

PMID:
28281332
17.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

18.

Chloro Derivatives of Azafullerenes C59 NCl5 and Non-Classical C97 NCl21.

Markov VY, Troyanov SI.

Chem Asian J. 2017 Feb 1;12(3):298-301. doi: 10.1002/asia.201601564. Epub 2017 Jan 6.

PMID:
28060440
19.

Fullerene as Photocatalyst: Visible-Light Induced Reaction of Perfluorinated α,ω-Diiodoalkanes with C60.

Vorobiev AK, Gazizov RR, Borschevskii AY, Markov VY, Ioutsi VA, Brotsman VA, Sidorov LN.

J Phys Chem A. 2017 Jan 12;121(1):113-121. doi: 10.1021/acs.jpca.6b10718. Epub 2017 Jan 3.

PMID:
27982596
20.

N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.

Francis JS, Wojtas I, Markov V, Gray SJ, McCown TJ, Samulski RJ, Bilaniuk LT, Wang DJ, De Vivo DC, Janson CG, Leone P.

Neurobiol Dis. 2016 Dec;96:323-334. doi: 10.1016/j.nbd.2016.10.001. Epub 2016 Oct 4.

Supplemental Content

Loading ...
Support Center